NephroPlus Expands Operations in the Philippines with Acquisition of Six Additional Dialysis Clinics

NephroPlus, Asia’s largest dialysis network (Source: Frost & Sullivan Report), has strengthened its footprint in the Philippines through the acquisition of six additional dialysis clinics. This expansion raises its nationwide presence to 39 clinics, providing high-quality, patient-centric care to more than 2,093 patients.

The newly acquired clinics are located in Zamboanga City, Santiago (Isabela), Cabuyao (Laguna), Binondo (Manila), CP Garcia Avenue (Diliman, Quezon City), and E. Rodriguez Avenue (Quezon City). The move forms part of NephroPlus’s international growth strategy and highlights its long-term commitment to improving access to dialysis care in the Philippines.

Renowned for integrating advanced technology and data-driven care models, NephroPlus leverages remote patient monitoring and real-time clinical data analytics to achieve superior clinical outcomes and operational efficiency.

With a global network of more than 490 clinics across five countries and 290+ cities, NephroPlus delivers life-sustaining dialysis treatment to over 32,000 patients every month. This positions the company as a worldwide leader in kidney care (Source: Frost & Sullivan Report).

Rohit Singh, Group CEO of NephroPlus, emphasized the importance of this milestone:

“This expansion marks a major milestone in our journey in the Philippines, which has now become our second-largest country of operations after India. We are deeply honoured by the trust placed in us by doctors, patients, and the broader healthcare ecosystem. As we grow, we remain steadfast in our mission to support the Philippines’ goal of achieving universal health coverage — through infrastructure development, clinical innovation, workforce capacity-building, and an unwavering focus on delivering patient-first care.”

This development reaffirms NephroPlus’s mission to make world-class, affordable dialysis care more accessible, supporting both national healthcare goals and regional patient needs across Asia.